Total planned funding: $486,336,505
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $122,223,201 |
Zambia | $41,905,051 |
Mozambique | $41,285,294 |
South Africa | $37,325,784 |
Zimbabwe | $29,468,423 |
Tanzania | $27,727,369 |
Asia Regional Program | $24,871,345 |
Kenya | $22,391,579 |
West Africa Region | $18,148,918 |
Vietnam | $17,457,923 |
Botswana | $11,774,003 |
Guyana | $10,995,000 |
Democratic Republic of the Congo | $9,922,555 |
Rwanda | $9,393,797 |
Côte d'Ivoire | $8,895,402 |
Namibia | $8,575,914 |
Ethiopia | $8,501,467 |
Burundi | $6,232,133 |
Dominican Republic | $5,798,850 |
Malawi | $5,366,259 |
Uganda | $3,573,638 |
Papua New Guinea | $3,494,885 |
Eswatini | $3,071,755 |
Haiti | $2,642,000 |
Angola | $2,250,000 |
Lesotho | $1,888,960 |
India | $600,000 |
enumerations.Philippines | $300,000 |
Indonesia | $255,000 |
Caribbean Region | $0 |
South Sudan | $0 |
Ghana | $0 |
Organizational Types
NGO | $486,336,505 |
Program Areas
Treatment | $103,125,920 |
Care | $81,903,748 |
Prevention | $76,503,758 |
Testing | $38,551,850 |
Governance and Systems | $27,867,854 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $96,790,943 |
HVOP: Sexual Prevention: Other Sexual Prevention | $50,686,850 |
HKID: Care: Orphans and Vulnerable Children | $48,227,439 |
HVCT: Testing: HIV Testing and Counseling | $38,551,850 |
HBHC: Care: Adult Care and Support | $23,821,783 |
OHSS: Health Systems Strengthening | $11,980,650 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,518,893 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,464,302 |
HLAB: Laboratory Infrastructure | $8,480,201 |
HVSI: Strategic Information | $7,407,003 |
PDTX: Treatment: Pediatric Treatment | $6,334,977 |
HVTB: Care: TB/HIV | $5,064,513 |
PDCS: Care: Pediatric Care and Support | $4,790,013 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,196,062 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,390,459 |
HMIN: Biomedical Prevention: Injection Safety | $188,760 |
HVMS: Management and Operations | $162,294 |
HMBL: Biomedical Prevention: Blood Safety | $58,432 |
HTXD: Treatment: ARV Drugs | $0 |